Published in Lancet on February 04, 1978
The association between primary biliary cirrhosis and coeliac disease: a study of relative prevalences. Gut (1998) 4.16
Risk of primary biliary liver cirrhosis in patients with coeliac disease: Danish and Swedish cohort data. Gut (1999) 1.79
HLA-DR phenotypes in Spanish coeliac children: their contribution to the understanding of the genetics of the disease. Gut (1983) 1.65
Primary biliary cirrhosis: an epidemiological study. Br Med J (1980) 1.48
Frequency and significance of anti-gliadin and anti-endomysial antibodies in autoimmune hepatitis. Dig Dis Sci (1998) 1.34
Primary biliary cirrhosis and adult celiac disease. West J Med (1992) 1.12
Hyposplenism, adult coeliac disease, and autoimmunity. Gut (1981) 1.11
Chronic hepatitis C virus and celiac disease, is there an association? Dig Dis Sci (2007) 1.03
Liver complications in celiac disease. Hepat Mon (2011) 1.01
Celiac disease and autoimmune-associated conditions. Biomed Res Int (2013) 0.99
Autoantibodies in chronic hepatitis C: A clinical perspective. World J Hepatol (2015) 0.96
Hepatic manifestations of celiac disease. Clin Exp Gastroenterol (2010) 0.91
Primary biliary cirrhosis and autoimmune cholangitis are not associated with coeliac disease in Crete. BMC Gastroenterol (2002) 0.91
Coeliac disease and liver dysfunction. Arch Dis Child (2002) 0.90
Hepatobiliary and pancreatic disorders in celiac disease. World J Gastroenterol (2006) 0.87
Celiac sprue among US military veterans: associated disorders and clinical manifestations. Dig Dis Sci (1999) 0.85
The role of celiac disease in severity of liver disorders and effect of a gluten free diet on diseases improvement. Hepat Mon (2013) 0.78
Association of primary sclerosing cholangitis and celiac disease: a case report and review of the literature. Dig Dis Sci (2004) 0.77
Liver involvement in pediatric celiac disease. World J Gastroenterol (2015) 0.77
Hepatic abnormalities in coeliac disease: three cases of delayed diagnosis. Postgrad Med J (1989) 0.76
To screen or not to screen? Celiac antibodies in liver diseases. World J Gastroenterol (2017) 0.75
Hepatobiliary disorders in celiac disease: an update. Int J Hepatol (2010) 0.75
Risks of bleeding peptic ulcer associated with individual non-steroidal anti-inflammatory drugs. Lancet (1994) 6.89
Quantitation of intraepithelial lymphocytes in human jejunum. Gut (1971) 6.18
Frequency of "functional" gastrointestinal disorders. Lancet (1977) 5.73
Folate levels and neural tube defects. Implications for prevention. JAMA (1995) 5.42
Risk assessment after acute upper gastrointestinal haemorrhage. Gut (1996) 5.02
Selection of patients for early discharge or outpatient care after acute upper gastrointestinal haemorrhage. National Audit of Acute Upper Gastrointestinal Haemorrhage. Lancet (1996) 4.55
Policy alternatives for resource allocation. Lancet (1977) 4.52
Minimum effective dose of folic acid for food fortification to prevent neural-tube defects. Lancet (1997) 4.11
Endoscopy in gastrointestinal bleeding. Lancet (1974) 4.02
Unmetabolized folic acid in serum: acute studies in subjects consuming fortified food and supplements. Am J Clin Nutr (1997) 3.75
Homocysteine metabolism in pregnancies complicated by neural-tube defects. Lancet (1995) 3.70
Similarities in intestinal humoral immunity in dermatitis herpetiformis without enteropathy and in coeliac disease. Lancet (1990) 3.37
Recommendations for standards of sedation and patient monitoring during gastrointestinal endoscopy. Gut (1991) 3.27
Intraepithelial lymphocytes of the small intestine. Gut (1977) 3.21
Omeprazole versus placebo for acute upper gastrointestinal bleeding: randomised double blind controlled trial. BMJ (1992) 3.17
Sedation for upper gastrointestinal endoscopy: results of a nationwide survey. Gut (1991) 3.14
The effect of antigen deprivation on thymus-dependent and thymus-independent lymphocytes in the small intestine of the mouse. Clin Exp Immunol (1972) 3.09
Selective migration of lymphocytes within the mouse small intestine. Immunology (1974) 3.06
A critical review of adaptive genetic variation in Atlantic salmon: implications for conservation. Biol Rev Camb Philos Soc (2007) 2.98
Changes in clinical features of coeliac disease in adults in Edinburgh and the Lothians 1960-79. Br Med J (Clin Res Ed) (1983) 2.91
Risk factors for complication following ERCP; results of a large-scale, prospective multicenter study. Endoscopy (2007) 2.88
Maternal plasma folate and vitamin B12 are independent risk factors for neural tube defects. Q J Med (1993) 2.69
Autoantibodies to tissue transglutaminase as predictors of celiac disease. Gastroenterology (1998) 2.68
14C-urea breath analysis, a non-invasive test for Campylobacter pylori in the stomach. Lancet (1987) 2.68
Randomised comparison of olsalazine and mesalazine in prevention of relapses in ulcerative colitis. Lancet (1992) 2.63
Prevention of hypoxaemia during upper-gastrointestinal endoscopy by means of oxygen via nasal cannulae. Lancet (1987) 2.60
Immunological responses to fed protein antigens in mice. I. Reversal of oral tolerance to ovalbumin by cyclophosphamide. Immunology (1982) 2.50
Intestinal inflammation in cystic fibrosis. Arch Dis Child (2000) 2.46
Low bone mineral density in Crohn's disease, but not in ulcerative colitis, at diagnosis. Gastroenterology (1994) 2.45
Too many patients, too few cardiologists to care? Can J Cardiol (2006) 2.45
Prospective survey of childhood inflammatory bowel disease in the British Isles. Lancet (2001) 2.44
The effects of different component response requirements in multiple and concurrent schedules. J Exp Anal Behav (1978) 2.43
Cell-mediated immunity to gliadin within the small-intestinal mucosa in coeliac disease. Lancet (1975) 2.41
Intravenous midazolam: a study of the degree of oxygen desaturation occurring during upper gastrointestinal endoscopy. Br J Clin Pharmacol (1987) 2.36
What is value for money in medical care? Experiences in England and Wales, Sweden, and the U. S. A. Lancet (1967) 2.36
Prevalence and "incidence" of celiac disease in Edinburgh and the Lothian region of Scotland. Gastroenterology (1986) 2.34
Intraepithelial cells in the human intestinal mucosa. J Ultrastruct Res (1971) 2.31
A case-control study of oesophageal adenocarcinoma in women: a preventable disease. Br J Cancer (2000) 2.27
Precipitins to dietary proteins in serum and upper intestinal secretions of coeliac children. Br Med J (1972) 2.25
Importance of both folic acid and vitamin B12 in reduction of risk of vascular disease. Lancet (2002) 2.25
Mortality in celiac disease. Gastroenterology (1989) 2.24
Failure to record variables of growth and development in children with inflammatory bowel disease. BMJ (1989) 2.22
Increased incidence of non-Hodgkin's lymphoma in inflammatory bowel disease patients on immunosuppressive therapy but overall risk is low. Gut (2000) 2.17
Smoking and Crohn's disease. Br Med J (Clin Res Ed) (1984) 2.17
Hospital caseloads in Liverpool, New England, and Uppsala. An international comparison. Lancet (1968) 2.12
Human intestinal mucosal mast cells: evaluation of fixation and staining techniques. J Clin Pathol (1981) 2.11
Thermolabile variant of 5,10-methylenetetrahydrofolate reductase associated with low red-cell folates: implications for folate intake recommendations. Lancet (1997) 2.10
Lymphocytes in Whipple's disease. Lancet (1968) 2.06
Endocinch therapy for gastro-oesophageal reflux disease: a one year prospective follow up. Gut (2003) 2.06
A genetic defect in 5,10 methylenetetrahydrofolate reductase in neural tube defects. QJM (1995) 2.05
Smoking and ulcerative colitis. Br Med J (Clin Res Ed) (1984) 2.05
Cigarette smoking and inflammatory bowel disease. Gastroenterology (1987) 2.04
Variation in outcome after acute upper gastrointestinal haemorrhage. The National Audit of Acute Upper Gastrointestinal Haemorrhage. Lancet (1995) 2.03
Appendicectomy, childhood hygiene, Helicobacter pylori status, and risk of inflammatory bowel disease: a case control study. Gut (1998) 2.02
Hypersensitivity reactions in the small intestine. III. The effects of allograft rejection and of graft-versus-host disease on epithelial cell kinetics. Cell Tissue Kinet (1977) 2.00
Immunological responses to fed protein antigens in mice. II. Oral tolerance for CMI is due to activation of cyclophosphamide-sensitive cells by gut-processed antigen. Immunology (1983) 1.99
Recent treatment with H2 antagonists and antibiotics and gastric surgery as risk factors for Salmonella infection. BMJ (1994) 1.99
Inflammatory bowel disease and male infertility: effects of sulfasalazine and 5-aminosalicylic acid on sperm-fertilizing capacity and reactive oxygen species generation. Fertil Steril (1989) 1.98
The "thermolabile" variant of methylenetetrahydrofolate reductase and neural tube defects: An evaluation of genetic risk and the relative importance of the genotypes of the embryo and the mother. Am J Hum Genet (1999) 1.94
Randomised controlled trial of azathioprine withdrawal in ulcerative colitis. BMJ (1992) 1.94
Intraepithelial lymphocyte count and crypt hyperplasia measure the mucosal component of the graft-versus-host reaction in mouse small intestine. Gastroenterology (1982) 1.92
Hypersensitivity in the small intestinal mucosa. V. Induction of cell-mediated immunity to a dietary antigen. Clin Exp Immunol (1981) 1.91
Hypermethylation of 14-3-3 sigma (stratifin) is an early event in breast cancer. Oncogene (2001) 1.89
Diagnosis of gluten-sensitive enteropathy: is exclusive reliance on histology appropriate? Eur J Gastroenterol Hepatol (1998) 1.87
A randomized controlled study on the effectiveness of a multifaceted intervention program in the primary prevention of asthma in high-risk infants. Arch Pediatr Adolesc Med (2000) 1.85
Gastrointestinal amyloidosis in psoriatic arthritis. Ann Rheum Dis (1968) 1.81
Reduction of gastrointestinal protein loss by elemental diet in Crohn's disease of the small bowel. Gut (1981) 1.77
Hypersensitivity reactions in small intestine. I Thymus dependence of experimental 'partial villous atrophy'. Gut (1975) 1.74
Intraepithelial lymphocyte counts in small intestinal biopsies from children with diarrhoea. Acta Paediatr Scand (1976) 1.73
Homocysteine and ischemic heart disease: results of a prospective study with implications regarding prevention. Arch Intern Med (1998) 1.72
Peptic ulcer bleeding: accessory risk factors and interactions with non-steroidal anti-inflammatory drugs. Gut (2000) 1.69
Audit of mortality in upper gastrointestinal bleeding. Postgrad Med J (1989) 1.68
Growth and development of "antigen-free" grafts of foetal mouse intestine. J Pathol (1972) 1.68
What predicts failed cannulation and therapy at ERCP? Results of a large-scale multicenter analysis. Endoscopy (2012) 1.68
Comparison of a low dose polyethylene glycol electrolyte solution with lactulose for treatment of chronic constipation. Gut (1999) 1.67
Risks, costs, and compliance limit colorectal adenoma surveillance: lessons from a randomised trial. Gut (2001) 1.63
Lipoprotein(a) in cirrhosis. BMJ (1992) 1.63
Adult coeliac disease in hyposplenic patients. Lancet (1970) 1.63
The outcome of the first 165 orthotopic liver transplants in Scotland. Scott Med J (1999) 1.63
Alpha gliadin antibody levels: a serological test for coeliac disease. Br Med J (Clin Res Ed) (1983) 1.62
Hypersensitivity reactions in the small intestine. 2. Effects of allograft rejection on mucosal architecture and lymphoid cell infiltrate. Gut (1976) 1.62
Intestinal antibody pattern of celiac disease: occurrence in patients with normal jejunal biopsy histology. Gastroenterology (1993) 1.61
Dissociation between systemic and mucosal humoral immune responses in coeliac disease. Gut (1991) 1.61
Immune responses to fed protein antigens in mice. 3. Systemic tolerance or priming is related to age at which antigen is first encountered. Pediatr Res (1984) 1.60
Gut inflammation in children with cystic fibrosis on high-dose enzyme supplements. Lancet (1995) 1.59
Humoral response to wheat protein in patients with coeliac disease and enteropathy associated T cell lymphoma. Br Med J (Clin Res Ed) (1986) 1.59
Clinical features, morbidity and mortality of Scottish children with inflammatory bowel disease. Q J Med (1990) 1.56
Carotinaemia. Br Med J (1942) 1.55
Hypersensitivity reactions in the small intestine. 6. Pathogenesis of the graft-versus-host reaction in the small intestinal mucosa of the mouse. Transplantation (1981) 1.54
Anal and dry sex in commercial sex work, and relation to risk for sexually transmitted infections and HIV in Meru, Kenya. Sex Transm Infect (2006) 1.53
A comparative study of emergency transjugular intrahepatic portosystemic stent-shunt and esophageal transection in the management of uncontrolled variceal hemorrhage. Am J Gastroenterol (1995) 1.52
Use of whole-gut lavage to measure intestinal immunity in healthy Sierra Leonean children. J Pediatr Gastroenterol Nutr (1994) 1.51
Cellobiose/mannitol sugar permeability test complements biopsy histopathology in clinical investigation of the jejunum. Gut (1984) 1.49
An analysis of cases incorrectly coded as inflammatory bowel disease in Scottish Hospital In-Patient Statistics (SHIPS). Scott Med J (1991) 1.49